LLY - Eli Lilly in charts: Verzenio and Mounjaro drive revenue growth while Humalog and Trulicity decline
2024-02-06 07:28:18 ET
More on Eli Lilly, Eli Lilly and Company, etc.
- Eli Lilly: GLP-1's Potential In More Indications Should Unlock Significant Value
- Biotech And Pharma Diversification Pays Off
- Eli Lilly: The Cupboard Is Fully Stocked
- Eli Lilly beats in Q4 as obesity drug sales blow past estimates
- Eli Lilly beats top-line and bottom-line estimates; initiates FY24 outlook